JP2018076267A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018076267A5 JP2018076267A5 JP2016220339A JP2016220339A JP2018076267A5 JP 2018076267 A5 JP2018076267 A5 JP 2018076267A5 JP 2016220339 A JP2016220339 A JP 2016220339A JP 2016220339 A JP2016220339 A JP 2016220339A JP 2018076267 A5 JP2018076267 A5 JP 2018076267A5
- Authority
- JP
- Japan
- Prior art keywords
- following formula
- compound represented
- salt
- active ingredient
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 6
- 239000004480 active ingredient Substances 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 206010012438 Dermatitis atopic Diseases 0.000 claims 1
- 102000012141 Peroxisome proliferator-activated receptor alpha Human genes 0.000 claims 1
- 239000012190 activator Substances 0.000 claims 1
- 201000008937 atopic dermatitis Diseases 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 108091008725 peroxisome proliferator-activated receptors alpha Proteins 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016220339A JP6755778B2 (ja) | 2016-11-11 | 2016-11-11 | ＰＰＡＲα活性化剤 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016220339A JP6755778B2 (ja) | 2016-11-11 | 2016-11-11 | ＰＰＡＲα活性化剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018076267A JP2018076267A (ja) | 2018-05-17 |
| JP2018076267A5 true JP2018076267A5 (enExample) | 2019-10-24 |
| JP6755778B2 JP6755778B2 (ja) | 2020-09-16 |
Family
ID=62149932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016220339A Active JP6755778B2 (ja) | 2016-11-11 | 2016-11-11 | ＰＰＡＲα活性化剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP6755778B2 (enExample) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007522259A (ja) * | 2004-10-20 | 2007-08-09 | ドゥサン コーポレーション | ホスファチジルセリンを含有する皮膚保・改善用あるいは皮膚バリア機能強化用の組成物 |
| WO2010073011A2 (en) * | 2008-12-23 | 2010-07-01 | Betagenon Ab | Compounds useful as medicaments |
| US9566310B2 (en) * | 2012-09-10 | 2017-02-14 | Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Reno | Methods of treating muscular dystrophy |
-
2016
- 2016-11-11 JP JP2016220339A patent/JP6755778B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018024670A5 (enExample) | ||
| JP2020503249A5 (enExample) | ||
| JP2019194236A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| JP2010501534A5 (enExample) | ||
| JP2021502388A5 (enExample) | ||
| EP4616908A3 (en) | Oxysterols and methods of use thereof | |
| JP2015522045A5 (enExample) | ||
| JP2017514877A5 (enExample) | ||
| JP2019089762A5 (enExample) | ||
| JP2013532130A5 (enExample) | ||
| JP2018150298A5 (enExample) | ||
| JP2015516427A5 (enExample) | ||
| CL2017001479A1 (es) | Combinación farmacéutica que comprende un agonista selectivo del receptor s1p1 | |
| JP2016102092A5 (enExample) | ||
| JP2018030858A5 (enExample) | ||
| JP2018116258A5 (enExample) | ||
| CN110139863A (zh) | 作为雌激素受体降解剂的吲哚并取代哌啶类化合物 | |
| JO3610B1 (ar) | مشتقات كربوكساميد | |
| MX383577B (es) | Derivados sustituidos de guanidina. | |
| JP2015042663A5 (enExample) | ||
| WO2015001541A3 (en) | Pharmaceutical film composition | |
| CN111406050A (zh) | 吲哚胺2,3-双加氧酶抑制剂及其用途 | |
| JP2018519528A5 (enExample) | ||
| WO2015130547A8 (en) | Bis-cyclic guanidine compound compositions, methods of use and treatment thereof |